A published case series reports unexpected cancer remissions linked with fenbendazole use, prompting renewed discussion on ...
As of Monday, December 22, BeyondSpring Inc.’s BYSI share price has dipped by 9.36%, which has investors questioning if this is right time to buy.
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.
Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback